Who should not take Thymosin Alpha-1 (Tα1)?
Documented caution flags for Thymosin Alpha-1 (Tα1) include active immunosuppression therapy (talk to provider) and pregnancy / nursing. This is not exhaustive, and absence from this list is not a safety clearance. Anyone pregnant, nursing, or managing a serious medical condition should only consider it under a doctor's care, and safety data for Thymosin Alpha-1 (Tα1) is limited.
Documented caution flags for Thymosin Alpha-1 (Tα1)
- Active immunosuppression therapy (talk to provider)
- Pregnancy / nursing
Reported side effects to weigh
- Generally well tolerated
- Mild injection-site irritation
References
- Thymosin alpha 1 in chronic hepatitis B and C — Sherman KE et al., Gut, 2003
- The efficacy and safety of thymosin alpha1 for sepsis (TESTS): multicentre, double blinded, randomised, placebo controlled, phase 3 trial — Wu J et al., BMJ, 2025
- The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial — Wu J et al., Critical Care, 2013
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on Thymosin Alpha-1 (Tα1)
Full Thymosin Alpha-1 (Tα1) breakdownThymosin Alpha-1 (Tα1) what it's used forThymosin Alpha-1 (Tα1) side effectsThymosin Alpha-1 (Tα1) how to take itThymosin Alpha-1 (Tα1) mistakes to avoidThymosin Alpha-1 (Tα1) half-lifeThymosin Alpha-1 (Tα1) how long to workThymosin Alpha-1 (Tα1) legal statusThymosin Alpha-1 (Tα1) how it worksthymosin alpha 1 vs ll 37Ask the AI Coach
Last updated 2026-06-15.